Feiba

Feiba is a medicine made from human plasma that helps blood clot, even if you have low or missing clotting factors.

Form
infuusiokuiva-aine ja liuotin, liuosta varten
Strength
100 U/ml
Active Ingredient
Factor VIII inhibitor bypassing activity
Manufacturer
Baxalta Innovations GmbH

How to Use

Dosage

Your doctor will decide your dose, usually 50-100 units of Feiba per kg of body weight.

Method

Feiba is given slowly into a vein after the powder is dissolved with the provided liquid, at an infusion rate of 2-10 units per kg of body weight per minute.

Important

Do not exceed 200 units of Feiba per kg of body weight per day.

Possible Side Effects

COMMON
  • •Hypersensitivity
  • •Headache
  • •Dizziness
  • •Low blood pressure
  • •Rash
  • •Positive hepatitis B surface antigen test
RARE
  • •Fibrin depletion syndrome (DIC), a severe blood clotting disorder
  • •Increased inhibitor titer
  • •Anaphylactic reactions
  • •Hives all over the body
  • •Numbness in limbs
  • •Abnormal or decreased sensation
  • •Stroke (thrombotic stroke, embolic stroke)
  • •Drowsiness
  • •Altered taste
  • •Heart attack (myocardial infarction)
  • •Rapid heart rate (tachycardia)
  • •Blood clot formation that travels in blood vessels (thromboembolic events, venous or arterial thrombosis)
  • •Increased blood pressure
  • •Redness
  • •Pulmonary embolism (lung blood clot)
  • •Airway constriction (bronchospasm)
  • •Wheezing
  • •Cough
  • •Shortness of breath
  • •Vomiting
  • •Diarrhea
  • •Abdominal pain
  • •Nausea
  • •Facial numbness
  • •Swelling of face, tongue, and lips (angioedema)
  • •Itching
  • •Pain at injection site
  • •General malaise
  • •Feeling of warmth (hot flush)
  • •Chills
  • •Fever
  • •Chest pain
  • •Chest discomfort
  • •Blood pressure decrease
  • •Increased fibrin D-dimer in blood
  • •Stinging pain or numbness in the face, arms or legs, and a drop in blood pressure (with rapid infusion)

Important Warnings

  • Do not use Feiba if you are allergic to the active substance or any other ingredient.
  • Do not use Feiba if you have disseminated intravascular coagulation (DIC), a severe blood clotting disorder.
  • If you have had a heart attack, blood vessel blockage, or blood clot, Feiba should only be used for life-threatening bleeding.
  • If you experience symptoms like skin redness, rash, itching, swelling of lips or tongue, breathing difficulties, chest tightness, malaise, dizziness, or a drop in blood pressure, stop the infusion immediately and contact your doctor.
  • If your blood pressure or heart rate changes strongly, or you have breathing difficulties, cough, or chest pain, stop the infusion immediately and contact your doctor.
Show 3 more warnings
  • Concomitant use with recombinant Factor VIIa (rFVIIa) may increase the risk of blood clots.
  • Do not use the product if the package or sterile seal is damaged, or if the solution is cloudy or contains particles.
  • Do not store in the refrigerator after reconstitution; use the solution within three hours.